Zydus receives final approval from US FDA for Colestipol Hydrochloride tablets
Colestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Lifesciences
Sentynl Therapeutics and BridgeBio Pharma announce asset purchase agreement for Nulibry
Under the terms of the agreement, Sentynl will acquire global rights to Nulibry, and will be responsible for its ongoing…
Zydus receives DCGI approval for Oxemia to treat anaemia in CKD patients
OxemiaTM (Desidustat) is an oral tablet formulation which is the first-in-India alternative to injectable…
Cadila Healthcare renamed as Zydus Lifesciences
Zydus unveils its ‘innovation and care’-centric corporate brand identity